TAG ARCHIVES FOR Belmont Principles

27
May2021

Guest blogger Anthony Peña discusses SACHRP's work to expand upon the role of justice in the Belmont Report. SACHRP’s task is to identify where holes exist in the ethical framework and regulations, and comment on what is needed to respond. Underscored by current events, this is overdue work that needs to result in rapid updates to IRB discourse and operations. Read more

18
May2021

As COVID-19 vaccinations have ramped up, there has been a parallel surge in discussion of the legality, ethics, and practicality of so-called vaccine passports: systems or processes that require COVID-19 vaccination in order to participate in certain activities. On the SBER Network, a PRIM&R Online Community, discussion emerged about whether institutions could mandate COVID-19 vaccinations for those participating in research, what role IRBs might play in that conversation, and the principles we should take into account as we consider the question. Read more

19
Jan2021

Last year, Heather H. Pierce, JD, MPH and I shared some thoughts about the Belmont Report at 40, and about the evolution and flexibility of the Belmont principles of respect for persons, beneficence, and justice in the face of changing circumstances. As we leave behind the extraordinary year of 2020, I have been thinking about how the pandemic, together with the Black Lives Matter social justice movement, has shone new, and I would say welcome, light on the principle of justice in research. Read more

3
Nov2020

Amid both promising and worrying signs in the development of treatments and vaccines for COVID-19, and in the context of a considerable amount of scrutiny of medical research, some researchers, ethicists, and advocates are working to make sure science doesn’t lose sight of a critical issue: diversity in the clinical trial participant pool. The distribution of research benefits to participants—and the consideration of race in subject selection—is tightly woven into the Belmont Report and has been a mainstay in research ethics discussion ever since. But despite the decades-long consideration of race and ethnicity in clinical trials, many trials still don’t enroll populations that reflect the diversity of the general populace or the group affected by the condition being studied. Read more